Why Virtualize Clinical Trials?
About 10 percent of new drugs complete the first phase of a clinical trial but patient participation drops by 30
Read moreAbout 10 percent of new drugs complete the first phase of a clinical trial but patient participation drops by 30
Read moreClinical trials are often unsuccessful or incomplete due to the huge costs and other issues associated with recruitment and keeping
Read morePrescreening potential subjects in oncology clinical trials is one of the most significant limiting factors in identifying eligible participants which
Read moreThe goals of drug development process involves supporting all stakeholders in improving patient care, addressing challenges associated with financial sustainability
Read moreThe average man and woman are working harder than ever before, and this is reflected by the fact that they
Read moreIron deficiency continues to be a major global health challenge, and a 2017 study reported that, over a 12 year
Read moreWhen a wound heals, the skin only returns to 70% of it’s previous strength. However, the growing capabilities of medical science means that
Read moreTechnological advances are raising the bar in medicine in so many ways, with everything from medical microchips to cloud solutions and automation
Read moreTitanium is a highly-prized metal known for its medical applications. With its amazing properties, the material is commonly found in
Read moreCancers develop in diversified and heterogeneous forms – breast, stomach, skin, cervical, leukemias and lymphomas and all of which are
Read more